Recognizing When a Treatment Change Is Warranted in Relapsing MSIn addition to insufficient efficacy as assessed by new clinical relapses or new MS lesions on MRI, the American Academy of Neurology (AAN) practice guideline gives equal...3 min read
Screening for the Comorbidities That Accelerate MS DisabilityIn the multiple sclerosis (MS) population, particularly in the older MS population, comorbidities can contribute to disability worsening. Comorbidities require...4 min read
Addressing Sexual Health in Relapsing MS CareAsked to rate how negatively multiple sclerosis (MS) affects each area of life on a 1 to 7 scale where 7 is significant negative impact, 39.4 percent of respondents...3 min read
Distinguishing Pseudo-Relapse From True Relapse and ProgressionThree clinically distinct events can result in the same report from the patient: my symptoms are worse. A true MS relapse reflects new inflammatory...4 min read
Relapsing MS Clinical ChallengeMuch of relapsing multiple sclerosis (MS) follow-up comes down to carefully obtaining detailed clinical history, performing comprehensive neurologic examinations, and reviewing...1 min read
Reassessing Disease Control in Relapse-Free PatientsAn MS patient who has not relapsed in a year meets the usual definition of controlled disease. In the 2026 Multiple Sclerosis In America survey, 47.6 percent of respondents...3 min read
Hear+Now: An AI-Powered Audio Digest – Patients Who Have Stopped Disease-Modifying TherapyA significant share of patients with multiple sclerosis are no longer on disease-modifying therapy — but the reasons behind that vary widely,...4 min read
